Cargando…
Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease
Alexander disease is a fatal neurodegenerative disease caused by mutations in the astrocyte intermediate filament glial fibrillary acidic protein (GFAP). The disease is characterized by elevated levels of GFAP and the formation of protein aggregates, known as Rosenthal fibers, within astrocytes. Lit...
Autores principales: | LaPash Daniels, Christine M., Paffenroth, Elizabeth, Austin, Elizabeth V., Glebov, Konstantin, Lewis, Diana, Walter, Jochen, Messing, Albee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574949/ https://www.ncbi.nlm.nih.gov/pubmed/26378915 http://dx.doi.org/10.1371/journal.pone.0138132 |
Ejemplares similares
-
Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes
por: Boyd, Michelle M., et al.
Publicado: (2021) -
Nitric oxide mediates glial-induced neurodegeneration in Alexander disease
por: Wang, Liqun, et al.
Publicado: (2015) -
Refining the concept of GFAP toxicity in Alexander disease
por: Messing, Albee
Publicado: (2019) -
The effect of glial fibrillary acidic protein expression on neurite outgrowth from retinal explants in a permissive environment
por: Toops, Kimberly A, et al.
Publicado: (2012) -
GFAP expression as an indicator of disease severity in mouse models of Alexander disease
por: Jany, Paige L., et al.
Publicado: (2013)